AMD and Intel have now published a full technical specification for ACE — AI Compute Extensions — the most significant overhaul to x86 AI compute in the architecture's history, co-authored by eight ...

Ongoing research into AI agent framework security identified an exploit chain in AutoGen Studio (AutoGen’s open-source prototyping user interface) that allows untrusted web content rendered by a ...

Read how Microsoft Security has advanced its agentic vulnerability detection system, codename MDASH, integrating into ...

Medical large language models (LLMs) are increasingly being used in clinical settings. For example, AI is helping doctors in ...

Shanku Niyogi of Databricks walks through the architecture behind Lakebase, LTAP and Lakehouse//RT – and renames an industry ...

CMS rulemaking or Congress should remove the outdated coverage exclusion on obesity treatment for Medicare beneficiaries. Efforts to fix this gap have stalled due to cost, stigma, and poor design. For ...

A security researcher has released exploit code for a Visual Studio Code (VS Code) zero-day vulnerability that allows attackers to steal GitHub authentication tokens by tricking users into clicking a ...

NEW YORK, June 2 (Reuters) - Health insurer Cigna (CI.N), opens new tab will stop covering GLP-1 weight-loss drugs including Novo Nordisk's (NOVOb.CO), opens new tab Wegovy and Eli Lilly's (LLY.N), ...

Your browser does not support the audio element. Licensed practical nurse and registered nurse coverage did not decline significantly in states that adopted laws to ...

The top pharmacy benefit manager in the U.S., CVS Caremark, will restore coverage obesity products from Eli Lilly, allowing patients to gain access to injected Zepbound and oral Foundayo through their ...

All major US pharmacy benefit managers now cover Lilly's obesity treatments CVS includes Foundayo as a co-preferred weight-loss drug starting Monday It will restart Zepbound coverage on October 1 Sign ...

CVS Health said it will restore coverage of Eli Lilly's blockbuster weight loss injection Zepbound and start covering its new obesity pill on its standard drug plans. The move supports Lilly's efforts ...